Showing results (51-60 of 183) with videos related to
Sort By:
Pageof 19
ACS Nano|October 14, 2011
Reshaping the future of nanopharmaceuticals: ad iudiciumS Moein Moghimi, Dan Peer, Robert LangerBiomaterials|June 15, 2010
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activationRanit Kedmi, Noa Ben-Arie, Dan PeerCancer Metastasis Reviews|May 8, 2015
Nanomedicine as an emerging platform for metastatic lung cancer therapyDalit Landesman-Milo, Srinivas Ramishetti, Dan PeerJournal of Drug Targeting|April 1, 2016
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticlesSrinivas Ramishetti, Dalit Landesman-Milo, Dan PeerJournal of Controlled Release : Official Journal of the Controlled Release Society|September 28, 2016
ECM-based macroporous sponges release essential factors to support the growth of hematopoietic cellsNeta Soffer-Tsur, Dan Peer, Tal DvirExpert Opinion on Drug Delivery|September 17, 2014
Overcoming multidrug resistance with nanomedicinesAssaf Ganoth, Keren Cohen Merimi, Dan PeerExpert Opinion on Drug Delivery|June 14, 2016
Harnessing nanomedicine for therapeutic intervention in glioblastomaAnna Gutkin, Zvi R Cohen, Dan PeerCancer Letters|September 1, 2014
Modulating cancer multidrug resistance by sertraline in combination with a nanomedicineVelthe Drinberg, Rivka Bitcover, Wolf Rajchenbach, et al.Journal of Drug Targeting|October 9, 2018
Targeting central nervous system pathologies with nanomedicinesShoshy Mizrahy, Anna Gutkin, Paolo Decuzzi, et al.Cancer Research|October 20, 2004
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor modelsDan Peer, Yaron Dekel, Dina Melikhov, et al.Pageof 19